Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Takeda gets positive CHMP opinion for Entyvio for UC and Crohn’s disease
The Pharma Letter
Saturday, March 22, 2014 - 12:46pm
tags:
Takeda, vedolizumab, Entyvio, ulcerative colitis, Crohn's Disease
Genentech wins FDA approval for Xolair to treat hives
San Francisco Chronicle, CA
Saturday, March 22, 2014 - 12:19pm
tags:
Genentech, Xolair, hives
Experimental J&J psoriasis drug shows promise in study
Yahoo/Reuters
Saturday, March 22, 2014 - 12:10pm
tags:
JNJ, psoriasis, guselkumab
From Plant to Prescription: 5 Ways Marijuana Made It to the Market
Wall St Cheat Sheet
Saturday, March 22, 2014 - 11:49am
tags:
marijuana
Gilead offers Egypt new hepatitis C drug at 99 pct discount
Yahoo/Reuters
Saturday, March 22, 2014 - 11:48am
tags:
Gilead Sciences, hepatitis C, Sovaldi
The Pfizer Drama That Wasn't
Motley Fool
Saturday, March 22, 2014 - 11:44am
tags:
Pfizer
Celgene Wins U.S. Approval for Psoriatic Arthritis Pill
Bloomberg
Saturday, March 22, 2014 - 11:41am
tags:
Otezla, Celgene Corporation, psoriatic arthritis
Zogenix CEO Goes on the Offensive
Yahoo/24-7 Wallstreet
Saturday, March 22, 2014 - 11:39am
tags:
Zogenix, Zohydro, pain management
Endocyte, Merck Cancer Drug Scores Twice
investors.com
Saturday, March 22, 2014 - 11:36am
tags:
Endocyte, Merck, Vynfinit, ovarian cancer
CytRx Misled Investors According to a Recently Filed Class Action
Yahoo/PR NewsWire
Saturday, March 22, 2014 - 11:33am
tags:
CytRx, lawsuits
Biotech Tweets of the Week: Gilead Sciences and Orexigen
Motley Fool
Saturday, March 22, 2014 - 11:32am
tags:
Gilead Sciences, Orexigen
Biogen Idec CEO talks drugs in pipeline, keys to growth (video)
CNBC
Saturday, March 22, 2014 - 11:30am
tags:
Biogen Idec
Does Mannkind Offer a Good Risk to Reward Ratio?
Motley Fool
Saturday, March 22, 2014 - 11:28am
tags:
MannKind
Biotechs, Medicals Get Hurt Amid Price-Inquiry News
investors.com
Saturday, March 22, 2014 - 11:26am
tags:
Biotech Stocks Weak on Fear That Gilead Drug Pricing Woes Will Spread
TheStreet.com
Friday, March 21, 2014 - 11:56am
tags:
drug pricing, Gilead Sciences, Sovaldi, biotech, hepatitis C
What the Heck Happened (Again) to Biotech?
Barron's
Friday, March 21, 2014 - 11:55am
tags:
biotech, Gilead Sciences, Biogen Idec
U.S. lawmakers ask Gilead about Sovaldi pricing
Yahoo/Reuters
Friday, March 21, 2014 - 11:54am
tags:
drug pricing, Sovaldi, hepatitis C, Gilead Sciences
They're no Coca-Cola, but top biopharma brands Pfizer, Biogen and Merck still worth billions
Fierce Pharma Marketing
Friday, March 21, 2014 - 10:44am
tags:
Pfizer, Biogen Idec, Merck
Did Endocyte Just Become Buyout Bait?
Wall St 24/7
Friday, March 21, 2014 - 10:39am
tags:
Endocyte, M&A, Merck, vintafolide
J&J-Medivir Hepatitis C Drug Recommended by EU Regulator
Bloomberg
Friday, March 21, 2014 - 10:21am
tags:
JNJ, hepatitis C, Europe, Medivir, Olysio

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.